Coverage of the English national human papillomavirus (HPV) immunisation programme among 12 to 17 yearold females by area-level deprivation score, England, 2008 to 2011

Eurosurveillance

Volumn 19, Issue 2, 2014, Pages

  Hughes, A ^a   Mesher, D ^a   White, J ^a   Soldan, K ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CONTROL; CANCER SCREENING; CHILD; FEMALE; GENERAL PRACTITIONER; HEALTH CARE SURVEY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MASS IMMUNIZATION; MASS SCREENING; UNITED KINGDOM; UTERINE CERVIX CANCER; WART VIRUS;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; DELIVERY OF HEALTH CARE; EARLY DETECTION OF CANCER; ENGLAND; FEMALE; HEALTHCARE DISPARITIES; HUMANS; IMMUNIZATION PROGRAMS; MASS VACCINATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84892767414     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.2.20677     Document Type: Article

References (21)

1. Department of Health (DH). Annual HPV vaccine coverage in England in 2010/11. London: DH. [Accessed 03 Apr 2013]. Available from: http://media.dh.gov.uk/network/211/ files/2012/03/120319_HPV_UptakeReport2010-11-revised_acc. pdf
2. Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J et al. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE 2010 survey. Euro Surveill. 2010;15(47):pii=19730. Available from: http:// www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19730
3. King LA, Levy-Bruhl D, O'Flanagan, Bacci A, Lopalco PL, Kudjawu Y et al. Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: results of the Venice 2007 survey. Euro Surveill. 2008;13(33):pii=18954. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=18954
4. Australian Government, Department of Health and Aging. National HPV Vaccination Programme coverage. Canberra: Australian Government, Department of Health and Aging. [Accessed 16 Jan 2013]. Available from: http://www.immunise. health.gov.au/internet/immunise/publishing.nsf/Content/ immunise-hpv
5. Centres for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(34): 671-7.
6. Centres for Disease Control and Prevention (CDC). Progress toward implementation of human papillomavirus vaccination-the Americas 2006-2010. MMWR Morb Mortal Wkly Rep. 2011;60(40): 1382-4.
7. Bach PB. Gardasil: from bench, to bedside, to blunder. Lancet. 2010;375(9719): 963-4. http://dx.doi.org/10.1016/S0140-6736(09)62029-8
8. Desai S, Soldan K, White J, Sheridan A, Gill ON. Human papillomavirus vaccine coverage. Lancet. 2010;376(9738):328-9. http://dx.doi.org/10.1016/S0140-6736(10)61179-8
9. Department of Health (DH). Annual HPV vaccine uptake in England: 2008/09. London: DH. [Accessed 18 Jul 2012]. Available from: http://www.dh.gov.uk/prod_consum_dh/ groups/dh_digitalassets/@dh/@en/@ps/documents/ digitalasset/dh_111676.pdf
10. Department of Health (DH). Annual HPV vaccine coverage in England in 2009/10. London: DH. [Accessed 03 Apr 2013]. Available from: https://www.gov.uk/government/uploads/ system/uploads/attachment_data/file/147510/dh_123826.pdf. pdf
11. Department for Communities and Local Government (DCLG). The English Indices of Deprivation 2010. London: DCLG. [Accessed 17 Jul 2012]. Available from: http://www. communities.gov.uk/publications/corporate/statistics/ indices2010
12. The NHS Information Centre, Screening and Immunisations team. Cervical Screening Programme-England, 2010-11. NHS. 24 Nov 2011. Available from: http://www.cancerscreening.nhs. uk/cervical/cervical-statistics-bulletin-2010-11.pdf
13. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. Journal of the American Statistical Association. 1979;74(368):829-36. http://dx.doi.org/10.1080/01621459.1979.10481038
14. Brisson M, Drolet M, Malagón T. Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination. J Natl Cancer Inst. 2013;105(3):158-61. http://dx.doi.org/10.1093/jnci/djs638
15. Sadler L, Roberts S, Mandal D, Barbin L. Risk and prevention behaviours amongst HPV vaccinated and unvaccinated young women. Presentation at: Eurogin;2012;Prague.
16. Hibbitts S, Jones J, Powell N, Dallimore N, McRea J, Beer H, et al. Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a crosssectional study. Br J Cancer. 2008;99(11):1929-33. http://dx.doi.org/10.1038/sj.bjc.6604748
17. Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003;105(5):687-91. http://dx.doi.org/10.1002/ijc.11141
18. Roberts SA, Barbin L, Stretch R, Baxter D, Elton P, Kitchener H, et al. Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiol Infect. 2011;139(3): 400-5. http://dx.doi.org/10.1017/S095026881000066X
19. Cottrell S, Roberts R, Thomas D. Factors affecting uptake of HPV vaccination in Wales. Abstract presented at: Health Protection Conference; Sep 2012.
20. Sinka K, Kavanagh K, Gordon R, Love J, Potts A, Donaghy M, et al. Achieving high and equitable coverage of adolescent HPV vaccine in Scotland. J Epidemiol Community Health. 2014;68(1):57-63. http://dx.doi.org/10.1136/jech-2013-202620
21. Choi YH, Jit M, Gay N, Cox A, Garnett GP, Edmunds WJ. Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom. Vaccine. 2010;28(24):4091-102. http://dx.doi.org/10.1016/j.vaccine.2009.09.125